Testicular Cancer
The OHSU Knight Cancer Institute provides expert, team-based care for testicular cancer. This cancer tends to strike younger men and is highly treatable. We offer you:
- Doctors with advanced training and expertise in urologic and reproductive cancers.
- Providers from a range of specialties who meet twice a month to combine their expertise patient by patient.
- Oregon’s only program that addresses the needs of patients diagnosed with cancer at ages 15 to 39.
- Specialists who can offer options to protect your fertility.
- A full array of support services for you and your family.
Understanding testicular cancer
The testicles are part of the male reproductive system. These two oval-shaped organs are held in a sac of skin called the scrotum, behind the penis. They make sperm cells to fertilize a female egg for pregnancy. They also make hormones such as testosterone.
What is testicular cancer?
Testicular cancer occurs when cells in the testicles grow out of control. The testicles are made up of several types of cells, which can develop into different types of cancer.
Male genitourinary anatomy
Who gets testicular cancer?
About 10,000 people in the U.S. are diagnosed with testicular cancer every year, according to the National Cancer Institute, and 300,000 people are living with it.
Risk factors include:
- Age: Patients tend to be younger. About half of patients are age 20 to 34 when diagnosed. About one-quarter are ages 35 to 44.
- Race/ethnicity: White men have a much higher risk than Black men or men of Asian descent.
- Undescended testicle: People born with one or both testicles still in the abdomen are at higher risk.
- History of cancer: Men with cancer in one testicle have a higher risk of developing it in the other testicle.
- Family history: Having a parent or sibling with testicular cancer increases risk, though few cases overall have a family link.
- HIV infection: Having HIV (human immunodeficiency virus, the infection that causes AIDS) raises risk.
- Precancerous cells: A condition called carcinoma in situ, in which abnormal cells are found in a testicle, is linked to higher risk.
What causes testicular cancer?
Scientists don’t know what causes testicular cancer. Some evidence indicates a genetic link, and research is ongoing.
When researchers look at the genes that may cause cancer, they focus on chromosomes. Chromosomes are the part of our cells that hold the DNA that guides human development. Most testicular cancer cells have an extra copy of part of a chromosome called isochromosome 12p. Some types have other chromosomal changes, suggesting that more research is needed.
Testicular cancer survival rates
A key concept in understanding survival is five-year relative survival rate. This is the percentage of people who are still alive five years after they were first diagnosed, compared to the general population. (It doesn’t count death from other causes.)
The five-year relative survival rate for testicular cancer is 95%, according to the National Cancer Institute.
It's important to remember that these figures are averages and can't predict the outcome for any one patient. It's also important to remember that these figures are based on the treatments that were available more than five years ago. Patients who are diagnosed now may have a better outlook. Treatments are getting better all the time.
Testicular cancer symptoms
Signs of testicular cancer vary and may be similar to those of other conditions. If you have any of these symptoms, talk with your doctor. Testicular cancer is most treatable when found early.
- A lump or fluid in the scrotum
- Pain or discomfort in the scrotum
- Sensation of heaviness in the scrotum
- Low back pain
- Chest pain or cough
- Breast tenderness or enlargement
Diagnosing testicular cancer
Screening tests may include:
Testicular exam: Your doctor will look for lumps or swelling, which could lead to more tests.
Ultrasound: This noninvasive imaging test uses sound waves to identify lumps and to see if they’re solid or fluid-filled. It can help tell cancerous cells from tumors that may not be cancer. If you have testicular cancer, your doctors may do other imaging tests to see if the cancer has spread.
Blood tests: Your doctors may be able to narrow down the type of cancer and its stage using a blood test. These tests look for substances called “tumor markers.” They include a high level of a protein called human chorionic gonadotropin, or HCG.
Biopsy/surgery: Your care team may want to confirm testicular cancer by looking at a tissue sample under a microscope. Unlike with many other cancers, doctors don’t use a needle or incision to get a sample because that can spread cancer cells. Instead, they remove the testicle and use follow-up tests to make sure no cancer is left.
Types of testicular tumors
If you have a testicular tumor, your doctors will identify its type. This will help guide your treatment plan.
Germ cell tumors: Most testicular cancers arise from reproductive cells called germ cells, which make sperm. Subtypes are:
- Seminomas make up 50% of germ cell tumors. They grow relatively slowly. Nearly all patients with this type are ages 25 to 45.
- Nonseminomas are more aggressive and likely to spread. Patients with this type tend to be in their late teens to early 30s.
Stromal cell tumors: Tumors in stromal cells, which make hormones, are usually not cancer. They make up less than 5% of adult testicular tumors.
Testicular cancer staging
Staging helps your care team judge how advanced your cancer is. This helps them plan the most effective treatment recommendations. Unlike most other cancers, testicular cancer staging includes a measure of tumor markers in your blood.
Stage I: The tumor has invaded as far as the scrotum. Tumor marker levels are not available or haven’t been checked.
Stage IA: The tumor is limited to the testicle. Tumor marker levels are normal.
Stage IB: The tumor may have spread as far as the scrotum. Tumor marker levels are normal.
Stage IS: At least one tumor marker level is high.
For Stages IIA-C, tumor marker levels are normal, or at least one is higher than normal.
Stage II: Cancer has spread to at least one nearby lymph node. Tumor marker levels are not available or haven’t been checked.
Stage IIA: Cancer is in no more than five lymph nodes, and no lymph node is larger than 2 centimeters across (about the size of a peanut).
Stage IIB: Cancer has spread to as many as five lymph nodes, and none is larger than 5 centimeters (about the size of a lime); or cancer has grown outside a lymph node.
Stage IIC: Cancer has spread to at least one nearby lymph node that is larger than 5 centimeters.
Stage III: Cancer has spread to a distant part of the body. Tumor marker levels are not available or haven’t been checked.
Stage IIIA: Cancer has spread to distant lymph nodes or to the lungs. Tumor marker levels are normal, or at least one is higher than normal.
Stage IIIB: At least one tumor marker is much higher than normal. Cancer has spread to at least one nearby lymph node, and the node may be larger than 5 centimeters. Or it has spread to distant lymph nodes or to the lungs.
Stage IIIC: One of the following:
- Cancer has spread to at least one nearby lymph node, and the node may be larger than 5 centimeters. At least one tumor marker level is very high.
- Cancer has spread to distant lymph nodes or to lungs, and at least one tumor marker level is very high.
- Cancer has spread to a distant organ other than the lungs.
Fertility preservation
If you wish to have children, our fertility experts will consult with you and your care team before treatment. You may start with cryopreservation, the long-term freezing of sperm. Removal of one testicle will not leave you infertile, but treatments such as radiation therapy and chemotherapy may damage sperm.
Testicular cancer treatments
Your care team will work with you to develop a treatment plan for your specific needs and wishes. Recommendations may include:
Monitoring
In some cases, we may advise closely monitoring the cancer with blood and imaging tests before deciding on next steps.
Orchiectomy
Surgery to remove a testicle is called orchiectomy. It may be done as part of your diagnosis and as treatment. Your surgeon will remove the testicle and the structures that connect it to your abdomen. This is done under general anesthesia or a local anesthetic.
Doctors make an incision in the lower abdomen to avoid touching other structures and possibly spreading the cancer. If your treatment plan calls for both testicles to be removed, we may also recommend hormone replacement to restore sexual function.
Lymph nodes: If cancer has spread to lymph nodes, these also may be removed, possibly with a minimally invasive technique. Lymph nodes, part of the immune system, are bean-size structures that filter unwanted substances.
Radiation therapy
Doctors often use radiation therapy for patients with testicular cancer. It may be used after surgery to target cancer cells that spread to nearby lymph nodes.
Options include:
- External beam radiation: A machine outside the body sends a beam of radiation to the cancer site. OHSU uses image-guided radiation therapy to precisely target cancer cells while sparing healthy tissue.
- Intensity modulated radiation therapy: IMRT is external radiation that uses computers to map the cancer in three dimensions. Radiation is shaped to the cancer, so we can deliver higher doses with less risk to normal tissue.
Chemotherapy
Chemotherapy medications kill cancer cells or stop them from reproducing. You may receive medications, alone or in combination, by mouth (as a pill or liquid) or in an IV.
Your care team may suggest chemotherapy after orchiectomy to keep cancer from coming back. Chemotherapy is also used when the cancer has spread beyond the testicle
Stem cell transplant
When your cancer does not respond to conventional treatment, your doctor may recommend a bone marrow/stem cell transplant. This gives your immune system new, healthy cells to help you fight the disease.
Reconstructive surgery
If you have a testicle removed, you may be eligible for reconstructive surgery to replace it with a prosthetic (artificial) one. Your urologist can discuss this option with you and your care team.
Additional OHSU services
- Our Adolescent and Young Adult Oncology Program provides support and other services for young people coping with cancer. The program’s director, Dr. Brandon Hayes-Lattin, survived testicular cancer after being diagnosed at age 28.
- The Knight Cancer Institute is at the forefront of research into promising new cancer treatments. Look for an OHSU clinical trial for testicular cancer.
- Scientists at our Cancer Early Detection Advanced Research Center, or CEDAR, are finding new ways to identify cancer when it’s most treatable. The center is in our Knight Cancer Research Building, which was designed to encourage collaboration among hundreds of researchers.
Learn more
- Testicular Cancer, National Cancer Institute
- Testicular Cancer, American Cancer Society
- Testicular Cancer, Cancer.Net, American Society of Clinical Oncology
- What is Testicular Cancer? Urology Care Foundation
- Testicular Cancer Foundation
For patients
Call 503-346-1500 to:
- Request an appointment
- Seek a second opinion
- Ask questions
Location
Knight Cancer Institute, South Waterfront
Center for Health & Healing, Building 2
3485 S. Bond Ave.
Portland, OR 97239
Free parking for patients and visitors
Refer a patient
- Refer your patient to OHSU.
- Call 503-494-4567 to seek provider-to-provider advice.
Cancer clinical trials
Clinical trials allow patients to try a new test or treatment.
Read more
Learn more about OHSU Knight Cancer Institute treatments:
Stay informed
News: Read about research breakthroughs, patient care and many other topics on our OHSU News site.